Saturday 17 October 2026
Export ONMD’s income statement to Excel — free account
OneMedNet Corporation
ONMD Healthcare Health Information Services
OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024. In the quarter to June 2026, revenue grew 88.4%, EPS fell 148.2%, free cash flow grew 14.1% and total debt rose 75.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.51
0.24
−5.05%
Follow ONMD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
390.68 | 0.00 | 0.00 | 0.00 |
P/S ratio |
115.87 | 36.06 | 35.67 | 28.35 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(32.83) | (28.61) | (30.49) | (22.00) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
118.73 | 35.97 | 36.08 | 28.59 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(7.55) | (6.52) | (6.61) | (6.05) | |
EV/FCF |
(7.51) | (6.50) | (6.60) | (6.03) | |
Quick Ratio |
0.27 | 0.33 | 0.19 | 0.22 | |
Current Ratio |
0.29 | 0.43 | 0.27 | 0.28 | |
Net Debt/EBITDA |
0.16 | 0.04 | (0.21) | (0.15) | |
Debt/Assets |
25.76% | 45.28% | 55.54% | 51.39% | |
Debt/Equity |
(0.10) | (0.33) | (0.21) | (0.20) | |
Asset Turnover |
0.17 | 0.46 | 0.81 | 0.79 | |
Operating CF/Net income |
2.36 | 0.55 | 0.63 | 0.86 | |
Capex/Depreciation |
0.00 | (0.56) | (0.18) | (1.80) | |
Interest Coverage |
(372.50) | (393.12) | (255.20) | (251.22) | |
Research and Development Expense of Revenue |
182.49% | 51.91% | 323.96% | 110.96% | |
Selling, General and Administrative Expense of Revenue |
954.80% | 322.13% | 1,938.54% | 469.86% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
80.23% | 166.85% | 448.96% | 158.56% | |
Graham Net Nets |
(0.07) | (0.06) | (0.09) | (0.09) | |
Graham Number |
0.00 | 3.07 | 2.92 | 4.77 | |
Earnings Yield |
0.26% | (5.72%) | (6.05%) | (23.42%) | |
Free Cash Flow Yield |
(13.65%) | (15.34%) | (15.32%) | (16.71%) | |
Revenue per Share |
0.03 | 0.20 | 0.02 | 0.05 | |
Operating CF per Share |
(0.33) | (0.38) | (0.28) | (0.32) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.33) | (0.39) | (0.28) | (0.32) | |
Cash per Share |
0.14 | 0.24 | 0.05 | 0.06 | |
Shareholders Equity per Share |
(0.75) | (0.67) | (0.74) | (0.61) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.75) | (0.67) | (0.74) | (0.61) | |
Free Cash Flow |
(1.75) | (1.72) | (1.54) | (1.88) | |
Working Capital |
(3.56) | (2.73) | (3.89) | (3.41) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | (0.01) | |
Net Current Asset Value |
(4.00) | (3.02) | (4.13) | (3.57) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.02 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.32 | 0.35 | 0.47 | 0.46 | |
Average Payables |
5.00 | 4.77 | 5.41 | 4.36 | |
Average Assets |
2.95 | 2.94 | 1.62 | 1.85 | |
Average Common Equity |
(9.10) | (9.46) | (10.31) | (3.68) |
Columns are period end dates · fundamentals updated 2 Oct 2026